Israel says it has made significant progress in developing new crown vaccine, ready for animal trials

The Israeli Prime Minister’s Office said in a March 31 statement that the Israel Institute of Biology had made progress in developing a vaccine against the new coronavirus and would soon conduct animal testing. The statement said that the institute director of the Institute of Biological Research, Shmuel Shapira reported to Prime Minister Benjamin Netanyahu the same day, the Institute has made “significant progress” in the development of a prototype vaccine against the new coronavirus, is preparing to carry out animal trials of the vaccine.

In early February, Netanyahu directed the Israel Institute of Biology to develop a vaccine against the new coronavirus and to establish a vaccine production plant.

In addition, the Israeli Polytechnic University announced on the 31st, researchers using 3D printing technology to develop a special “patch” attached to the mask of health care workers, help ingestthes the infection rate of health care workers. This special “patch” is made of nanofibers coated with disinfectants to enhance nanoparticle capture, effectively deterred from entering the mask. The patch has been initially approved by the Israeli Ministry of Health and is scheduled to be tested in the coming days.

According to data released by the Israeli Ministry of Health on the evening of the 31st, the day of the new 663 confirmed cases of new coronary pneumonia, the largest one-day increase since the outbreak in the country. As of the 31st, the cumulative number of confirmed cases was 5358 cases, of which 94 were serious, 4 new deaths, 20 cumulative deaths, 63 new cases of cure, a cumulative cure of 224 cases.

Israel says it has made significant progress in developing new crown vaccine, ready for animal trials